Back to results
US 2016/0243228 A1Published application
Methods, compositions, and kits for treatment of cancer
OwnerJocelyn HOLASH, Stephen LAUinventors
Life of this patent
Estimating the term…
Abstract
Provided herein are the use of FGFR3 inhibitors and PD1 inhibitors to treat solid and hematologic cancers and compositions and kits comprising an FGFR3 inhibitor and a PD1 inhibitor.
Claims21
A method of treating a solid tumor in a subject in need thereof comprising administering a therapeutically effective amount of an FGFR3 inhibitor in combination with a therapeutically effective amount of a PD1 inhibitor.
A pharmaceutical composition comprising an FGFR3 inhibitor and a PD1 inhibitor.
Dependencies are inferred from the claim text.